2024 Q2 Form 10-Q Financial Statement

#000146608524000054 Filed on April 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $158.4M $160.5M
YoY Change -3.39% -0.52%
Cost Of Revenue $465.0K $67.47M
YoY Change -99.33% 2.81%
Gross Profit $157.9M $93.06M
YoY Change 66.13% -2.8%
Gross Profit Margin 99.71% 57.97%
Selling, General & Admin $6.244M $8.381M
YoY Change 5.65% 2.78%
% of Gross Profit 3.95% 9.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $53.76M $53.32M
YoY Change -0.42% 0.82%
% of Gross Profit 34.04% 57.3%
Operating Expenses $60.37M $62.10M
YoY Change 0.8% 0.67%
Operating Profit $97.57M $30.96M
YoY Change 177.4% -9.09%
Interest Expense -$18.31M $20.60M
YoY Change -17.62% -6.87%
% of Operating Profit -18.77% 66.54%
Other Income/Expense, Net $0.00 -$1.000K
YoY Change -100.0% -101.08%
Pretax Income $10.56M $17.96M
YoY Change -3.94% 102.45%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $10.35M $17.58M
YoY Change -3.31% 103.25%
Net Earnings / Revenue 6.54% 10.95%
Basic Earnings Per Share $0.05 $0.08
Diluted Earnings Per Share $0.05 $0.08
COMMON SHARES
Basic Shares Outstanding 225.1M shares 224.8M shares
Diluted Shares Outstanding 225.4M shares 225.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.03M $21.28M
YoY Change 46.59% 70.91%
Cash & Equivalents $21.03M $21.28M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $69.83M $98.60M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $90.86M $119.9M
YoY Change -9.97% 863.03%
LONG-TERM ASSETS
Property, Plant & Equipment $5.668B $5.670B
YoY Change -8.81% -10.03%
Goodwill
YoY Change
Intangibles $0.00 $0.00
YoY Change
Long-Term Investments $90.35M $89.49M
YoY Change -9.62% -3.66%
Other Assets $26.36M $20.63M
YoY Change -6.39% -7.86%
Total Long-Term Assets $5.849B $5.853B
YoY Change -8.84% -9.69%
TOTAL ASSETS
Total Short-Term Assets $90.86M $119.9M
Total Long-Term Assets $5.849B $5.853B
Total Assets $5.940B $5.973B
YoY Change -8.86% -8.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.0M $83.68M
YoY Change -11.78% -20.96%
Accrued Expenses $9.150M $7.145M
YoY Change -17.17% -36.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $17.48M $19.63M
YoY Change 140.69% 131.63%
Total Short-Term Liabilities $165.6M $127.7M
YoY Change -3.08% -19.06%
LONG-TERM LIABILITIES
Long-Term Debt $2.235B $2.277B
YoY Change -15.45% -13.09%
Other Long-Term Liabilities $6.066M $8.928M
YoY Change -25.21% -17.78%
Total Long-Term Liabilities $2.241B $2.286B
YoY Change -15.48% -13.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $165.6M $127.7M
Total Long-Term Liabilities $2.241B $2.286B
Total Liabilities $2.407B $2.414B
YoY Change -18.73% -13.45%
SHAREHOLDERS EQUITY
Retained Earnings -$392.6M -$367.0M
YoY Change 63.61% 70.88%
Common Stock $3.757B $3.756B
YoY Change 0.0% 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.399B $3.424B
YoY Change
Total Liabilities & Shareholders Equity $5.940B $5.973B
YoY Change -8.86% -8.02%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $10.35M $17.58M
YoY Change -3.31% 103.25%
Depreciation, Depletion And Amortization $53.76M $53.32M
YoY Change -0.42% 0.82%
Cash From Operating Activities $83.02M $44.06M
YoY Change 3.41% -6.08%
INVESTING ACTIVITIES
Capital Expenditures $43.93M $38.66M
YoY Change -21.77% -7.17%
Acquisitions
YoY Change
Other Investing Activities $27.08M $294.1M
YoY Change -426.57% 1229.44%
Cash From Investing Activities -$16.85M $255.4M
YoY Change -73.85% -1408.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.68M -$308.3M
YoY Change 643.02% 742.93%
NET CHANGE
Cash From Operating Activities 83.02M $44.06M
Cash From Investing Activities -16.85M $255.4M
Cash From Financing Activities -60.68M -$308.3M
Net Change In Cash 5.498M -$8.832M
YoY Change -28.4% -3.83%
FREE CASH FLOW
Cash From Operating Activities $83.02M $44.06M
Capital Expenditures $43.93M $38.66M
Free Cash Flow $39.10M $5.401M
YoY Change 61.99% 2.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224706731 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
224706731 shares
CY2024Q1 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#DepreciationAndAmortization
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1 us-gaap Other Income
OtherIncome
203000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
239000 usd
CY2024Q1 us-gaap Revenues
Revenues
160534000 usd
CY2023Q1 us-gaap Revenues
Revenues
161374000 usd
CY2024Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
59971000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
59255000 usd
CY2024Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
7499000 usd
CY2023Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
6371000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8381000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8154000 usd
CY2024Q1 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.16
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53721000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53536000 usd
CY2024Q1 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLoss
-2301000 usd
CY2023Q1 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLoss
-151000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
131873000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
127467000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
20603000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
22124000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
10530000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
985000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
203000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
93000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-829000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-776000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
3213000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
384000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
224000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
17577000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8648000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224627115 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224226873 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225226270 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225088659 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
14463000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
-6913000 usd
CY2024Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-5239000 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-3377000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9224000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10290000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27185000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1418000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
620000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-65000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26565000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1353000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3567194000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
36187000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9224000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3460000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1598000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
951000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3559103000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3737867000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
31688000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10290000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4778000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3757000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-13000 usd
CY2023Q1 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.14
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
834000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3704935000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53721000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53536000 usd
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2395000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2755000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
697000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
939000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3389000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4734000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
10530000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
985000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
203000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 irt Amortization Or Adjustments Related To Derivative Instruments
AmortizationOrAdjustmentsRelatedToDerivativeInstruments
316000 usd
CY2023Q1 irt Amortization Or Adjustments Related To Derivative Instruments
AmortizationOrAdjustmentsRelatedToDerivativeInstruments
318000 usd
CY2024Q1 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss And Other Adjustments
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLossAndOtherAdjustments
-1184000 usd
CY2023Q1 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss And Other Adjustments
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLossAndOtherAdjustments
-151000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-829000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-776000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-312000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-970000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-835000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20779000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19121000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-772000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
266000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-332000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-967000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44057000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46911000 usd
CY2024Q1 us-gaap Payments To Acquire Real Estate And Real Estate Joint Ventures
PaymentsToAcquireRealEstateAndRealEstateJointVentures
1272000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate And Real Estate Joint Ventures
PaymentsToAcquireRealEstateAndRealEstateJointVentures
13438000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
292670000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
35557000 usd
CY2024Q1 irt Payments To Acquire Productive Assets Excluding Acquisition Of Real Estate Properties
PaymentsToAcquireProductiveAssetsExcludingAcquisitionOfRealEstateProperties
24561000 usd
CY2023Q1 irt Payments To Acquire Productive Assets Excluding Acquisition Of Real Estate Properties
PaymentsToAcquireProductiveAssetsExcludingAcquisitionOfRealEstateProperties
28973000 usd
CY2024Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
14095000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
12667000 usd
CY2024Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2661000 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
255403000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19521000 usd
CY2024Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
94000000 usd
CY2023Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
57000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
220152000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
55513000 usd
CY2024Q1 us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
142537000 usd
CY2023Q1 us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
1813000 usd
CY2024Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
663000 usd
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2024Q1 irt Payments Reimbursements For Deferred Financing Costs
PaymentsReimbursementsForDeferredFinancingCosts
242000 usd
CY2023Q1 irt Payments Reimbursements For Deferred Financing Costs
PaymentsReimbursementsForDeferredFinancingCosts
0 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
36149000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
31625000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
951000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
853000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1598000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3757000 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
13000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-308292000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36574000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8832000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9184000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50732000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44017000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34833000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21275000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12448000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
20625000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
22385000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34833000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1: Organization</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Independence Realty Trust, Inc. (“IRT”), is a self-administered and self-managed Maryland real estate investment trust (“REIT”) which was formed on March 26, 2009. We are primarily engaged in the ownership, operation, management, improvement, and acquisition of multifamily apartment communities in non-gateway markets. As of March 31, 2024, we owned and operated 111 (unaudited) multifamily apartment properties (including one owned through a consolidated joint venture) that contain an aggregate of 32,877 (unaudited) units across non-gateway U.S. markets, including Atlanta, Columbus, Dallas, Denver, Houston, Indianapolis, Nashville, Oklahoma City, Raleigh-Durham, and Tampa. In addition, as of March 31, 2024, we owned two investments in real estate under development in Denver, Colorado that will, upon completion, contain an aggregate of 621 (unaudited) units. As of March 31, 2024, we also owned interests in four unconsolidated joint ventures, two of which own and operate multifamily apartment communities that contain an aggregate of 810 (unaudited) units and two of which are developing multifamily apartment properties that will, upon completion, contain an aggregate of 653 (unaudited) units. We own all of our assets and conduct substantially all of our operations through Independence Realty Operating Partnership, LP, a Delaware limited partnership (“IROP”), of which we are the sole general partner.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the terms “we,” “our,” and “us” refer to IRT and, as required by context, IROP and its subsidiaries.</span></div>
CY2024Q1 irt Number Of Real Estate Properties Excluding Development Properties
NumberOfRealEstatePropertiesExcludingDevelopmentProperties
111 property
CY2024Q1 irt Number Of Unconsolidated Joint Venture
NumberOfUnconsolidatedJointVenture
1 jointventure
CY2024Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
32877 unit
CY2024Q1 irt Number Of Joint Ventures
NumberOfJointVentures
4 jointventure
CY2024Q1 irt Number Of Joint Ventures Own And Operate Apartment Communities
NumberOfJointVenturesOwnAndOperateApartmentCommunities
2 jointventure
CY2024Q1 irt Number Of Units In Developing Multifamily Apartment Community
NumberOfUnitsInDevelopingMultifamilyApartmentCommunity
810 unit
CY2024Q1 irt Number Of Operating Property
NumberOfOperatingProperty
2 property
CY2024Q1 irt Number Of Units In Operating Property Under Construction
NumberOfUnitsInOperatingPropertyUnderConstruction
653 unit
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20625000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27880000 usd
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P6M
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
399000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
398000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1099000 usd
CY2024Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
15107000 usd
CY2023Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Depreciation
Depreciation
53323000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
52887000 usd
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7276000 usd
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2920000 usd
CY2024Q1 us-gaap Incurred Claims Property Casualty And Liability
IncurredClaimsPropertyCasualtyAndLiability
2301000 usd
CY2023Q1 us-gaap Incurred Claims Property Casualty And Liability
IncurredClaimsPropertyCasualtyAndLiability
151000 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1570000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1454000 usd
CY2024Q1 us-gaap Real Estate Held For Development And Sale Net
RealEstateHeldForDevelopmentAndSaleNet
109338000 usd
CY2023Q4 us-gaap Real Estate Held For Development And Sale Net
RealEstateHeldForDevelopmentAndSaleNet
98365000 usd
CY2024Q1 irt Number Of Investments In Unconsolidated Real Estate Entities
NumberOfInvestmentsInUnconsolidatedRealEstateEntities
4 investment
CY2024Q1 irt Number Of Investments In Unconsolidated Real Estate Entities
NumberOfInvestmentsInUnconsolidatedRealEstateEntities
4 property
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21275000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21275000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22852000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
22852000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20625000 usd
CY2024Q1 irt Restricted Cash And Cash Equivalents Fair Value Disclosure
RestrictedCashAndCashEquivalentsFairValueDisclosure
20625000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27880000 usd
CY2023Q4 irt Restricted Cash And Cash Equivalents Fair Value Disclosure
RestrictedCashAndCashEquivalentsFairValueDisclosure
27880000 usd
CY2024Q1 irt Derivative Assets Carrying Value
DerivativeAssetsCarryingValue
38845000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
38845000 usd
CY2023Q4 irt Derivative Assets Carrying Value
DerivativeAssetsCarryingValue
29937000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
29937000 usd
CY2024Q1 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
64825000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2024Q1 irt Number Of Real Estate Properties Excluding Development Properties
NumberOfRealEstatePropertiesExcludingDevelopmentProperties
111 property
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2235000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2408000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2517000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2701000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
220000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
210000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
3213000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q1 irt Number Of Properties Owned By Joint Ventures
NumberOfPropertiesOwnedByJointVentures
1 property
CY2024Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
32877 unit
CY2024Q1 us-gaap Land
Land
536997000 usd
CY2023Q4 us-gaap Land
Land
540950000 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5190512000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5288956000 usd
CY2024Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
455500000 usd
CY2023Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
429306000 usd
CY2024Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6183009000 usd
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6259212000 usd
CY2024Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
622713000 usd
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
582760000 usd
CY2024Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5560296000 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5676452000 usd
CY2023Q4 irt Number Of Properties Targeting For Sale
NumberOfPropertiesTargetingForSale
10 property
CY2023Q4 irt Number Of Markets Targeting Sale Of Properties
NumberOfMarketsTargetingSaleOfProperties
7 market
CY2024Q1 irt Number Of Properties Sold
NumberOfPropertiesSold
9 property
CY2024Q1 irt Number Of Properties Targeting For Sale
NumberOfPropertiesTargetingForSale
10 property
CY2024Q1 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
496800000 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
488900000 usd
CY2024Q1 irt Number Of Units In Real Estate Property Disposed
NumberOfUnitsInRealEstatePropertyDisposed
1554 housingunit
CY2024Q1 irt Sale Price Of Real Estate Property
SalePriceOfRealEstateProperty
296125000 usd
CY2024Q1 irt Gains Losses On Sales Of Investment Real Estate During Period
GainsLossesOnSalesOfInvestmentRealEstateDuringPeriod
25637000 usd
CY2023Q4 irt Gains Losses On Sales Of Investment Real Estate Defeasance Costs
GainsLossesOnSalesOfInvestmentRealEstateDefeasanceCosts
921000 usd
CY2024Q1 irt Gains Losses On Sales Of Investment Real Estate During Period
GainsLossesOnSalesOfInvestmentRealEstateDuringPeriod
25637000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2024Q1 irt Number Of Units In Real Estate Property Held For Sale
NumberOfUnitsInRealEstatePropertyHeldForSale
546 housingunit
CY2024Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
98603000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2023Q4 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
7135000 usd
CY2024Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
292639000 usd
CY2024Q1 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
179293000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-829000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-776000 usd
CY2024Q1 irt Equity Method Investment Number Of Units After Development Is Complete
EquityMethodInvestmentNumberOfUnitsAfterDevelopmentIsComplete
1463 unit
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
89487000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
89044000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2247009000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9715000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-39804000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2277098000 usd
CY2024Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.048
CY2024Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.042
CY2024Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y10M24D
CY2024Q1 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
64825000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
19626000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
137235000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
447073000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
23681000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1035098000 usd
CY2024Q1 irt Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
584296000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2515698000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10772000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-44483000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2549409000 usd
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.048
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.042
CY2023 us-gaap Debt Instrument Term
DebtInstrumentTerm
P4Y
CY2023Q4 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
122621000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
250000000 usd
CY2023Q3 irt At Market Sales Agreement Maximum Offer Price Of Common Shares
AtMarketSalesAgreementMaximumOfferPriceOfCommonShares
450000000 usd
CY2024Q1 us-gaap Partners Capital Account Units Converted
PartnersCapitalAccountUnitsConverted
4928 shares
CY2024Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
5941643 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1280610 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
384000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
224000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
17577000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8648000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224627115 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224226873 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225226270 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225088659 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6540798 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5946571 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5946571 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001466085-24-000054-index-headers.html Edgar Link pending
0001466085-24-000054-index.html Edgar Link pending
0001466085-24-000054.txt Edgar Link pending
0001466085-24-000054-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irt-20240331.htm Edgar Link pending
irt-20240331.xsd Edgar Link pending
irt-2024331xexx311.htm Edgar Link pending
irt-2024331xexx312.htm Edgar Link pending
irt-2024331xexx321.htm Edgar Link pending
irt-2024331xexx322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
irt-20240331_lab.xml Edgar Link unprocessable
irt-20240331_pre.xml Edgar Link unprocessable
irt-20240331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
irt-20240331_cal.xml Edgar Link unprocessable
irt-20240331_def.xml Edgar Link unprocessable